INTERNEURON PHARMACEUTICALS INC
10-K405, EX-27, 2000-12-21
PHARMACEUTICAL PREPARATIONS
Previous: INTERNEURON PHARMACEUTICALS INC, 10-K405, EX-23, 2000-12-21
Next: DIGI INTERNATIONAL INC, DEF 14A, 2000-12-21



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AND STATEMENT OF OPERATIONS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                      24,871,000
<SECURITIES>                                 8,880,000
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            45,053,000
<PP&E>                                       1,338,000
<DEPRECIATION>                             (1,192,000)
<TOTAL-ASSETS>                              46,826,000
<CURRENT-LIABILITIES>                       18,728,000
<BONDS>                                              0
                                0
                                  3,500,000
<COMMON>                                        43,000
<OTHER-SE>                                  24,223,000<F1>
<TOTAL-LIABILITY-AND-EQUITY>                46,826,000
<SALES>                                              0
<TOTAL-REVENUES>                            24,754,000
<CGS>                                                0
<TOTAL-COSTS>                               11,248,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                             19,956,000
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                19,956,000
<EPS-BASIC>                                       0.47
<EPS-DILUTED>                                     0.46

<FN>
<F1> Additional paid-in-capital - $274,011,000
     Accumulated deficit - $(249,802,000)
     Accumulated other comprehensive income - $14,000
</FN>

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission